UH Seidman Cancer Center at Salem Regional Medical Center is a clinical research site located in Salem, Ohio, United States 44460.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
UH Seidman Cancer Center at Salem Regional Medical Center has participated in 12 clinical trials with 3 currently active.
Therapeutic areas: Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7.
Sponsors: National Cancer Institute (NCI), Gynecologic Oncology Group, GOG Foundation.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UH Seidman Cancer Center at Salem Regional Medical Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UH Seidman Cancer Center at Salem Regional Medical Center has 12 clinical trials on record, with 3 currently active. Their work covers Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7.
Yes — UH Seidman Cancer Center at Salem Regional Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.